The ki-67 immunohistochemical stainings in the shRNA1-treated tumors were remarkably lower than that in shRNA-neg-treated tumors, indicating that interference for WIP1 may restrain the proliferation of tumor cells. This evidence concerns the gene MKI67 and neoplasm.